Cardiovascular Health

Post-myocardial infarction patients who had each of their preventive medications on hand at least 80% of the time had significantly lower rates of major vascular events or revascularization than controls.

A new study estimates the costs of treating atrial fibrillation as well as the comparative costs of treating it with warfarin and newer oral anticoagulants.

The results of a recent study identified a relationship between cardiovascular disease and cognitive decline in postmenopausal women.

Atrial fibrillation patients were more likely to suffer a stroke within the first month of initiating treatment with warfarin when compared with those not using any antithrombotic therapy, according to the results of a recent study.

According to the results of a German study published in PLOS ONE, atrial fibrillation may increase the risk for depression.

A recent study published in the Annals of Internal Medicine finds that premature atrial contraction count may improve atrial fibrillation risk model performance.

An overview of "Get with the Guidelines " AFIB," a quality-improvement program created by the American Heart Association for health care providers.

Chris Cannon, MD, FACC, discusses 3 research papers on atrial fibrillation in this video produced by the American College of Cardiology.

Compared with previous hypertension treatment guidelines, the JNC 8 guidelines advise higher blood pressure goals and less use of several types of antihypertensive medications.

OTC case studies involving vitamin E supplementation, omega-3 fatty acid supplementation, smoking cessation, and weight-loss medication.

Nutritional supplements should never be used as a replacement for prescription antihyperlipidemic agents.

Helping patients select an appropriate blood pressure monitor and ensuring that they are comfortable using it are crucial for heart health.

Using a benefit-based approach instead of a treat-to-target approach in determining how to treat hypertension could help prevent more cardiovascular events with less medication.

A systematic review of previous studies finds no evidence of decreased cognitive function associated with statin use.

Patients at high cardiovascular risk who took aspirin at night had significantly reduced platelet reactivity compared with those who took aspirin in the morning, according to the results of a study.

Patients who took beta-blockers during non-cardiac surgery had increased risk of acute coronary syndrome, decompensated heart failure, and arrhythmia, according to the results of a study.

Newly released lipid guidelines have introduced a variety of changes in how clinicians determine whether patients should receive statins.

New guidelines from the American Heart Association and American College of Cardiology eliminate strict LDL cholesterol targets and include stroke risk in determining whether patients should take statins.

Risk of death from prostate cancer was reduced for patients who started taking statins after being diagnosed with the disease and was reduced even more for those who started taking statins before being diagnosed.

Patients need to achieve high levels of adherence to all the medications they are prescribed after a heart attack in order to reduce their risk of subsequent adverse cardiovascular events, a new study finds.

A range of trials has failed to resolve whether calcium supplementation significantly decreases the risk of fracture or increases the risk of cardiovascular events.

A meta-analysis of previous studies suggests that getting vaccinated against the flu reduces one's risk of adverse cardiovascular events, with the greatest benefit in those with a recent acute coronary syndrome.

The hospitalization rate for the most serious cardiovascular infection declined despite a recommendation from the American Heart Association to limit use of preventive antibiotics.

Issues in anticoagulation relating to mechanical valve replacement and diabetes patients on antithrombotics.

Apixaban (Eliquis) was recently approved as an oral anticoagulant (a direct inhibitor of factor Xa) to reduce the risk of embolism in patients with atrial fibrillation.